ARCHIVES

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: NCI closes its Tobacco Intervention Research Clinic, blaming flat budget, slow accrual.

October 15, 2004

Reinventing NCI: Natural Products Screen Closes; NCI Targets Drug Resistance

December 13, 1996

Trials Approved by NCI CTEP For the Month of January

January 27, 2012

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

March 30, 2001

Inspector General’s chronology Of Events In Gallo Research

July 1, 1994

Foundation Issues Call For Tobacco Policy Research Proposals

November 27, 1992